Effect of perceived and objectively-assessed frailty on outcomes in edoxaban-treated patients with atrial fibrillation: data from the ETNA-AF-Europe 4-year follow-up
FUMAGALLI, S., DIEMBERGER, I., BAKHAI, A., PECEN, Ladislav, LAMPARTER, M., KIRCHHOF, P., DE CATERINA, R. Effect of perceived and objectively-assessed frailty on outcomes in edoxaban-treated patients with atrial fibrillation: data from the ETNA-AF-Europe 4-year follow-up. European Heart Journal. 2023, 44(Suppl. 2). ISSN 0195-668X. E-ISSN 1522-9645 Dostupné z: doi:10.1093/eurheartj/ehad655.544